相关实验视频
Updated: Jan 17, 2026

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.8K
高MRPL12表达驱动食道癌的扩散,入侵和迁移
Guangxu Wang1, Xiaoming Sun2, Qiaoling Liu3
1School of Clinical Medicine, Shandong Second Medical University, Weifang 261000, Shandong, China; Department of Thoracic Surgery, Jinan Central Hospital, Jinan 250013, Shandong, China.
Bulletin du cancer
|September 18, 2025
概括
线粒体核糖体蛋白L12 (MRPL12) 在食道状细胞癌 (ESCC) 中被上调,促进瘤生长和迁移. 减少MRPL12可能为ESCC提供治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体功能障碍和代谢重编程与食道状细胞癌 (ESCC) 的发展有关.
- 线粒体核糖体蛋白L12 (MRPL12) 调节线粒体的新陈代谢和转录.
- 此前,MRPL12在食道瘤发生中的特定作用是未知的.
研究的目的:
- 研究MRPL12在食道状细胞癌 (ESCC) 中的作用.
- 确定MRPL12是否可以作为ESCC的预后生物标志物.
主要方法:
- 在ESCC组织和细胞系中使用西部涂抹,RT-qPCR和免疫组织化学进行MRPL12表达分析.
- 实验室功能研究涉及食道癌细胞系中MRPL12基因淘汰和过度表达.
- 细胞增殖,迁移和入侵的评估使用,Transwell和CCK-8试验.
主要成果:
- 在ESCC细胞和组织中,MRPL12显著上调.
- 过度表达MRPL12增强了ESCC细胞的增殖,迁移和入侵.
- 绝杀MRPL12抑制了这些恶性行为.
- 转录因子ZNF460和ZNF135被确定为MRPL12的关键调节者.
结论:
- 在ESCC的进展中,MRPL12起着重要作用.
- MRPL12是ESCC的潜在预后生物标志物.
- 向MRPL12表达可能是抑制ESCC进展的治疗策略.
相关概念视频
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K

